Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/34747
Title: Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997–2017
Authors: BRUYNDONCKX, Robin 
Hoxha, Ana
Quinten, Chantal
AYELE, Girma 
Versporten, Ann
Adriaenssens, Niels
Heuer, Ole
Monnet, Dominique L.
Goossens, Herman
MOLENBERGHS, Geert 
Weist, Klaus
HENS, Niel 
Coenen, Samuel
Muller, Arno
Issue Date: 2021
Publisher: OXFORD UNIV PRESS
Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (Supplement_2) , p. 68 -78
Abstract: Objectives: Surveillance of antibiotic consumption in the community is of utmost importance to inform and evaluate control strategies. Data on two decades of antibiotic consumption in the community were collected from 30 EU/European Economic Area (EEA) countries. This article reviews temporal trends and the presence of abrupt changes in subgroups of relevance in antimicrobial stewardship. Methods: For the period 1997-2017, data on yearly antibiotic consumption in the community, aggregated at the level of the active substance, were collected using the WHO ATC classification and expressed in DDD (ATC/DDD index 2019) per 1000 inhabitants per day. We applied a range of non-linear mixed models to assess the presence of changes in the consumption of antibacterials for systemic use (ATC group J01) and eight antibiotic subgroups. Results: For the majority of the studied groups, a country-specific change-point model provided the best fit. Depending on the antibiotic group/subgroup and on the country, change-points were spread out between 2000 and 2013. Conclusions: Due to the heterogeneity in antibiotic consumption in the community across EU/EEA countries, a country-specific change-point model provided the better fit. Given the limitations of this model, our recommendation for the included countries is to carefully interpret the country-specific results presented in this article and to use the tutorial included in this series to conduct their own change-point analysis when evaluating the impact of changes in regulations, public awareness campaigns, and other national interventions to improve antibiotic consumption in the community.
Notes: Bruyndonckx, R (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, Antwerp, Belgium.; Bruyndonckx, R (corresponding author), Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BIOST, Data Sci Inst, Hasselt, Belgium.
robin.bruyndonckx@uhasselt.be
Document URI: http://hdl.handle.net/1942/34747
ISSN: 0305-7453
e-ISSN: 1460-2091
DOI: 10.1093/jac/dkab179
ISI #: WOS:000684146500010
Rights: VC The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Category: A1
Type: Journal Contribution
Validations: ecoom 2022
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
dkab179.pdfPublished version632.33 kBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

9
checked on Apr 14, 2024

Page view(s)

26
checked on Jun 23, 2022

Download(s)

10
checked on Jun 23, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.